Patients with Joubert syndrome 2 (JBTS2) suffer from a neurological disease manifested by psychomotor retardation, hypotonia, ataxia, nystagmus, and oculomotor apraxia and variably associated with dysmorphism, as well as retinal and renal involvement. Brain MRI results show cerebellar vermis hypoplasia and additional anomalies of the fourth ventricle, corpus callosum, and occipital cortex. The disease has previously been mapped to the centromeric region of chromosome 11. Using homozygosity mapping in 13 patients from eight Ashkenazi Jewish families, we identified a homozygous mutation, R12L, in the TMEM216 gene, in all affected individuals. Thirty individuals heterozygous for the mutation were detected among 2766 anonymous Ashkenazi Jews, indicating a carrier rate of 1:92. Given the small size of the TMEM216 gene relative to other JBTS genes, its sequence analysis is warranted in all JBTS patients, especially those who suffer from associated anomalies.
Joubert syndrome (JBTS [MIM 213300]) is characterized by a specific midhindbrain malformation, hypotonia, cerebellar ataxia, and developmental delay. Oculomotor apraxia and abnormalities in breathing patterns are frequent findings. Associated anomalies include progressive retinal degeneration, 1 4 and both orofacial and digital
signs (OFDVI [MIM 277170])
. 5 So far, Joubert syndrome and related disorders (JSRDs) have been mapped to ten loci, and causative genes have been identified for nine of them. [6] [7] [8] [9] [10] Most encoded proteins were shown to localize to the cilia or to the centrosome, indicating that ciliary dysfunction is a key factor in the molecular pathogenesis of JSRDs. We now report on a mutated gene in the tenth locus, 11p12-q13.3, in JSRD patients of Ashkenazi Jewish origin. The subjects were 13 patients from eight Ashkenazi Jewish families. Three of the families belonged to the same clan. Pregnancy was uneventful in all cases, and all the infants in this series were born at term, with normal Apgar scores and appropriate weights for gestational age. In two cases, there was suspicion of posterior fossa abnormalities on the basis of prenatal ultrasound. The initial presentation, evident from birth, consisted of hypotonia, rotatory nystagmus, esotropia, and feeding difficulties due to oral motor dysfunction with associated impaired swallowing and mastication. The physical examination was notable for dolichocephaly and frontal bossing in six patients, metopic craniosynostosis in one patient, and macrocephaly (birth head circumference 41 cm) due to noncommunicating hydrocephalus in one patient. Three patients had postaxial polydactyly in the lower limbs, and two patients had it in their upper limbs as well.
Early psychomotor development was invariably delayed, and the cognitive functioning of all the patients was eventually in the mildly to severely retarded range. Over the first two years of life, the nystagmus improved in all the patients, and visual function, funduscopic examination, and visual evoked potential appeared normal thereafter. Oral motor difficulties were invariably present from birth, resulting in swallowing and chewing difficulties and, in most patients, failure to thrive. Serum transaminases were normal in all the patients. In eight patients, normal renal ultrasound was reported. However, two patients suffered from end-stage renal insufficiency since midadolescence (the clinical data are summarized in Table 1 ). In brain MRIs, the molar tooth sign (deep interpeduncular fossa; thick, elongated superior cerebellar peduncles and cerebellar vermis hypoplasia) was observed. Associated findings, a complete absence of the vermis with wide space between the cerebellar hemisphere or a dysplastic split vermis without an opening or separation of the cerebellar hemispheres were present in all of the patients (Figure 1) . Over the years, the patients underwent extensive metabolic and genetic investigations, including array comparative genomic hybridization, all of which yielded normal results.
Because was performed in three patients but invariably yielded normal results.
In order to localize the mutated gene, we performed homozygosity mapping, using the GeneChip Human Mapping 250K Nsp Array of Affymetrix, as previously described. 11 This study was initiated by the Dor Yeshorim organization at the request of families of patients affected with JBTS, and all patients' guardians provided informed consent for participation, in compliance with the research regulations regarding human subjects in Israel. Initially, the DNA samples of three second cousins originating from a single clan were analyzed. Comparing runs of homozygosity longer than 2.4 Mb in each patient, we detected only one homozygous region, spanning 4.46 Mb on chromosome 11 (SNP markers rs11228951-rs11230775, corresponding to 56.73-61.19 Mb; marker positions are provided in accordance with the March 2006 release of the UCSC Human Genome Assembly; build hg18), which was shared by the three patients; the genotypes of the 379 SNP markers that are included in this region were identical. We then analyzed the DNA samples of three additional patients originating from two unrelated (Figure 2 ), which is predicted to result in the substitution of arginine at codon 12 by leucine (R12L). In parallel, we took a complementary approach, determining the complete exonic sequence of a mother and an affected daughter by using array-based hybrid selection and deep sequencing.
12,13
Genomic DNA samples were fragmented and immortalized by ligation to standard Illumina adapters, followed by PCR-based enrichment. Sequences corresponding to all annotated human exons were enriched by hybridization to an Agilent 1 Million Feature Array. 14 Each sample was sequenced in two flow cell lanes on a GAIIx (Illumina), which yielded roughly 30 million paired-end sequence reads per sample. Our analysis did not reveal any potentially relevant insertions or deletions in the targeted region. We called SNPs with SOAPsnp, using a coverage cutoff of at least 53 in the 59-62 Mb region on chromosome 11. 15 All SNPs that were not homozygous in the daughter and heterozygous in the mother were discarded. Only 17 SNPs survived this filter (Table S1 , available online). Excluding SNPs that were already documented in dbSNP130 reduced the number of candidates to two. One had an obvious effect on a protein, changing amino acid 12 of TMEM216 from arginine to leucine. This was precisely the coding variant identified via combined linkage mapping and candidate resequencing. Thus, not only did these analyses independently support our candidate gene, but they also failed to reveal any similarly compelling potentially causal mutation. The R12L mutation was present in a homozygous state in all 13 patients. Carriers were detected via three different methods. First, direct sequencing was used as described above. Second, restriction fragment length polymorphism (RFLP) analysis was performed, whereby a 176 bp fragment was amplified via mismatch primer amplification (forward primer 5 0 -CCCAAGTGTGTGGCAGTTC-3 0 , reverse primer 5 0 -GGACAACACTTACCAAAAAACTGG-3 0 ), followed by BpmI digestion at 37 C for 2 hrs. In the presence of the mutation, the 176 bp fragment was digested to 136 bp and 40 bp fragments, which were then analyzed on 2% agarose gel. Finally, for mass carrier detection, we used the TaqMan JSRDs were heretofore mapped to ten loci, and causative genes have been identified for nine of them. The tenth locus, the centromeric region of chromosome 11 (11p12-q13.3), was mapped in six families, and this form was designated as JBTS2 (MIM 608091). The patients, originating from Sicily, Turkey, Pakistan, United Arab Emirates, and Portugal, suffered from a neurological disease with psychomotor retardation, breathing abnormalities in infancy (alternating brady-tachypnea), hypotonia, truncal ataxia, nystagmus, oculomotor apraxia, and impaired pursuit and saccades. Brain MRI showed the molar tooth sign variably associated with fourth-ventricle cyst, kinked corpus callosum, malformed occipital cortex, and hydrocephalus. Miscarried siblings had occipital encephalocele and enlarged cistern magna. Ophthalmologic abnormalities included microphthalmia, retinal coloboma, retinal dystrophy, and optic atrophy. Renal involvement ranged in severity from a urinary-concentration defect secondary to nephronophthisis to fulminent renal failure due to cystic renal dysplasia. Facial dysmorphism with hypertelorism, low-set ears, and a depressed nasal bridge, as well as postaxial polydactyly, were reported. The three coding exons of the TMEM216 (HSPC244) gene encode a small protein that consists of 87 amino acids, predicted to form two transmembrane domains. The amino acid arginine at codon 12 is conserved in the TMEM216 homologs in Danio rerio and Drosophila melanogaster, and its substitution by leucine is predicted to be deleterious by both the SIFT-BLink software and the PolyPhen software. The segregation of the mutation with the disease state in all family members and the absence of mutations in all other coding exons within the linked region suggest that this mutation is indeed pathogenic. Because all known JSRD genes were shown to localize to the primary cilia or basal body or to directly interact with their components (reviewed in Doherty 18 ), it is tempting to speculate a similar localization for the TMEM216 protein. Ciliary membranes contain receptors and ionchannel proteins mediating mechano-and chemosensations and other types of cell signaling, including Shh, Wnt, and PDGF-alpha signaling pathways. TMEM67/ MKS3 (Meckelin), a JSRD protein with seven transmembrane domains, was shown to localize both to the primary cilium and to the plasma membrane in ciliated cell lines and primary cells and to be of importance for centriole migration to the apical membrane and for the consequent formation of the primary cilium. 19 The elucidation of the role of the TMEM216 protein in this organelle and in JSRD2 pathogenesis is in progress. Given its small size in comparison to other JSRD genes, sequence analysis of TMEM216 is warranted in every JSRD patient, especially those who suffer from associated anomalies.
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